1139 GMT - GSK PLC is among the most mentioned companies across news items over the past 12 hours, according to Factiva data, after it posted higher sales and profit for the fourth quarter which beat consensus expectations. The British pharma major posted net profit of GBP1.50 billion, up from GBP749 million the year prior, on sales which rose to GBP7.38 billion. Operating profit and earnings per share beat analysts' expectations, coming in at GBP1.87 billion and 36.5 pence, respectively. Analysts had forecast operating profit to be GBP1.49 billion and EPS at 21.2 pence. The company posted record sales of its best-selling shingles vaccine Shingrix, AJ Bell analysts note, adding that 2022 was a landmark year for the company. Dow Jones & Co. owns Factiva. (cecilia.butini@wsj.com)

 

(END) Dow Jones Newswires

February 01, 2023 06:54 ET (11:54 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more GSK Charts.